TipRanks
Advertisement
Advertisement
Praxis Precision price target raised to $826 from $810 at BTIG
PremiumThe FlyPraxis Precision price target raised to $826 from $810 at BTIG
16d ago
Analyst Justin Walsh Reiterates Buy on Praxis as Upgraded Relutrigine Forecast Triples Long-Term Revenue Potential
Premium
Ratings
Analyst Justin Walsh Reiterates Buy on Praxis as Upgraded Relutrigine Forecast Triples Long-Term Revenue Potential
20d ago
Analyst Reiterates Buy on PRAX with Unchanged $582 Price Target Ahead of Key Phase 3 EMERALD Trial for Relutrigine
Premium
Ratings
Analyst Reiterates Buy on PRAX with Unchanged $582 Price Target Ahead of Key Phase 3 EMERALD Trial for Relutrigine
28d ago
Praxis Precision price target raised to $514 from $400 at Baird
PremiumThe FlyPraxis Precision price target raised to $514 from $400 at Baird
3M ago
Praxis Precision price target raised to $362 from $323 at Wells Fargo
Premium
The Fly
Praxis Precision price target raised to $362 from $323 at Wells Fargo
3M ago
Praxis Precision Medicines Reaffirmed With Buy Rating on FDA Progress and $1.4 Billion Cash Runway Supporting 2028 Launch Plans
Premium
Ratings
Praxis Precision Medicines Reaffirmed With Buy Rating on FDA Progress and $1.4 Billion Cash Runway Supporting 2028 Launch Plans
3M ago
Praxis Precision initiated with a Buy at Goldman Sachs
PremiumThe FlyPraxis Precision initiated with a Buy at Goldman Sachs
3M ago
Praxis Precision, Remagine Labs Partner on Ulixacaltamide Patch
Premium
Company Announcements
Praxis Precision, Remagine Labs Partner on Ulixacaltamide Patch
4M ago
Praxis Precision, Remagine Labs announce research collaboration and license pact
Premium
The Fly
Praxis Precision, Remagine Labs announce research collaboration and license pact
4M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―